Hemostemix Inc. (HMTXF)
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.
Sector: Biotechnology
Industry: Biotechnology
Hemostemix Inc.
OTC:HMTXFHealthcare · Biotechnology
-31.71%$0.0239
CLOSED · Nov 16Prev close$0.0350-31.71%Close$0.0239
Mkt Cap$5.05M
EV$7.05M
Float168.41M
O/S211.44M
VOL79K sh
$ Vol$2K
RVOL1.85×
Inst Own-
SI<0.1%
Net Cash/Sh-$0.01
Dilution
MCap$5.05MFloat168.41MO/S211.44M
Dilution
Financials Summary
Revenue$0
Net Income-$3.3M
Total Assets$592K
Free Cash Flow-$3.17M
Debt & Equity
Total Debt$2.52M
Total Equity-$3.48M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
- 1:20Reverse splitDec 30, 202020 shares → 1
Balance Sheet Details
Assets$592K
Liabilities$4.07M
Accounts Receivable$46K
Accounts Payable$1.21M
Inventory$0
PP&E (Net)$26
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $32 | $49 | $156 | $347 | $771 | $2K | $1K | $0 | $0 | $0 | $26K | $0 | $0 |
| Gross Profit | -$32 | -$49 | -$156 | -$347 | -$771 | -$2K | -$1K | $0 | $0 | $0 | -$26K | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $1.74M | $2K | $269K | $436K | $126K | $455K | $1.65M | $1.58M | $42K | $580K | $1.04M | $1.1M | $200K |
| Selling, General, and Administrative | $1.8M | $1.38M | $1.36M | $2.72M | $4.53M | $4.77M | $1.64M | $2.91M | $1.93M | $1.61M | $1.72M | $1.68M | $855K |
| Other | $405K | $20 | $79 | -$869K | $770 | $5K | $1K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $3.94M | $1.39M | $1.63M | $2.29M | $4.66M | $5.23M | $3.29M | $4.5M | $1.97M | $2.6M | $2.79M | $2.63M | $1.07M |
| Operating Income (EBIT) | -$3.94M | -$1.39M | -$1.63M | -$2.29M | -$4.67M | -$3.41M | -$3.29M | -$4.65M | -$1.97M | -$2.6M | -$2.76M | -$2.63M | -$1.05M |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | $392K | $438K | $385K | $245K | $7K | $74K | $73K | $0 | $797K | $2K | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $51K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $643K | -$446K | -$118K | -$1.03M | $87K | -$2.02M | -$122K | $169K | -$491K | -$99K | $30K | -$400K | -$1K |
| Income Before Tax (EBT) | -$3.3M | -$1.83M | -$1.75M | -$3.32M | -$4.58M | -$5.44M | -$3.41M | -$4.33M | -$2.46M | -$1.93M | -$2.77M | -$3.03M | -$1.06M |
| Income Tax Expense | $0 | $0 | $0 | $341K | -$179K | $0 | $0 | $4K | -$42K | -$7K | $16K | $7K | $18K |
| Net Income | -$3.3M | -$1.83M | -$1.75M | -$3.66M | -$4.4M | -$5.44M | -$3.41M | -$4.33M | -$2.75M | -$2.65M | -$2.79M | -$3.03M | -$1.08M |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||||
| EPS | -0.03 | -0.03 | -0.03 | -0.07 | -0.11 | -0.24 | -0.32 | -0.41 | -0.56 | -1.12 | -1.13 | -1.39 | -0.50 |
| Diluted EPS | -0.03 | -0.03 | -0.03 | -0.07 | -0.11 | -0.24 | -0.32 | -0.41 | -0.56 | -1.12 | -1.13 | -1.39 | -0.50 |
| Weighted Average OS | 163.44M | 93.44M | 82.50M | 69.98M | 57.45M | 32.24M | 15.04M | 14.93M | 6.98M | 3.37M | 3.52M | 3.12M | 3.05M |
| EBITDA | -$3.94M | -$1.39M | -$1.63M | -$2.29M | -$1.94M | -$3.41M | -$3.25M | $69 | -$1.94M | -$1.8M | -$2.76M | -$3M | -$1.04M |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Assets | |||||||||||||
| Current Assets | |||||||||||||
| Cash and Cash Equivalents | $477K | $494K | $109K | $95K | $154K | $181K | $17K | $1.03M | $2.77M | $24K | $355K | $2.31M | $246K |
| Short-Term Investments | $42K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $878K | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $519K | $494K | $109K | $95K | $154K | $181K | $17K | $1.03M | $3.65M | $24K | $355K | $2.31M | $246K |
| Accounts Receivable | $46K | $161K | $18K | $97K | $240K | $1.44M | $9K | $134K | $0 | $0 | $0 | $132K | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$240K | $0 | -$9K | -$62K | -$43K | -$52K | -$56K | -$187K | -$169K |
| Other Current Assets | $3 | $0 | $0 | $0 | $240K | $0 | $53K | $0 | $0 | $0 | $0 | $135K | $169K |
| Total Current Assets | $592K | $694K | $220K | $325K | $394K | $1.62M | $70K | $1.16M | $3.71M | $88K | $424K | $2.62M | $435K |
| Long-Term Assets | |||||||||||||
| Property, Plant & Equipment Net | $26 | $58 | $128 | $284 | $631 | $1K | $3K | $0 | $0 | $71K | $97K | $107K | $106K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $37K | $31K | $31K |
| Total Long-Term Assets | $27 | $59 | $129 | $285 | $631 | $1K | $3K | $0 | $0 | $71K | $134K | $138K | $137K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $592K | $694K | $220K | $326K | $394K | $1.63M | $73K | $1.16M | $3.71M | $159K | $558K | $2.76M | $572K |
| Liabilities | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | $1.21M | $1.94M | $1.84M | $1.83M | $2.32M | $1.38M | $728K | $549K | $244K | $667K | $287K | $251K | $44K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $123K | $1.45M | $0 | $0 | $755K | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3K | $5K | $24K | $31K |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | -$731K | $0 | $0 | $399K | $0 | $0 | $0 |
| Other Current Liabilities | -$987 | $1.35M | $1.52M | $2K | $738K | $889K | $1.46M | $273K | $45K | $546K | $5K | $24K | $120K |
| Total Current Liabilities | $1.21M | $1.94M | $2.01M | $1.83M | $3.06M | $2.4M | $2.9M | $822K | $325K | $2.36M | $436K | $386K | $170K |
| Long-Term Liabilities | |||||||||||||
| Long-Term Debt | $2.52M | $3.46M | $3.03M | $2.89M | $1.04M | $0 | $0 | $0 | $0 | $219K | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | -$341K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $341K | $341K | $341K | $341K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $341K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.86M | $3.8M | $3.37M | $3.23M | $1.04M | $0 | $0 | $0 | $0 | $219K | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $4.07M | $5.74M | $5.38M | $5.06M | $4.09M | $2.4M | $2.9M | $822K | $325K | $2.58M | $436K | $386K | $170K |
| Stockholders' Equity | |||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $33.84M | $30.74M | $29.74M | $28.76M | $27.07M | $26.53M | $21.72M | $21.72M | $21.52M | $15.47M | $15.37M | $14.8M | $10.17M |
| Retained Earnings | -$49.38M | -$46.12M | -$44.29M | -$42.54M | -$38.87M | -$34.47M | -$29.03M | -$25.62M | -$21.29M | -$18.54M | -$15.89M | -$13.1M | -$10.07M |
| Comprehensive Income & Other | $1.79M | $1.08M | $1.04M | $1.87M | $1.06M | $1.08M | $308K | $2.2M | $2.26M | $51K | $0 | $0 | $0 |
| Other Stockholders' Equity | $12.06M | $10.33M | $9.39M | $9.04M | $8.1M | $7.17M | $4.48M | $4.24M | $3.16M | $645K | $643K | $673K | $297K |
| Total Equity | -$3.48M | -$5.04M | -$5.16M | -$4.74M | -$3.7M | -$769K | -$2.83M | $341K | $3.39M | -$2.42M | $122K | $2.37M | $402K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $592K | $694K | $220K | $326K | $394K | $1.63M | $73K | $1.16M | $3.71M | $159K | $558K | $2.76M | $572K |
| Supplementary Data | |||||||||||||
| Total Debt | $2.52M | $3.46M | $3.03M | $2.89M | $1.04M | $123K | $1.45M | $0 | $0 | $974K | $0 | $0 | $0 |
| Net Debt | $2.04M | $2.96M | $2.92M | $2.79M | $884K | -$58K | $1.43M | -$1.03M | -$2.77M | $949K | -$355K | -$2.31M | -$246K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
| Operating Activities | |||||||||||||
| Net Income | -$3.3M | -$1.83M | -$1.75M | -$3.66M | -$4.4M | -$5.44M | -$3.41M | -$4.33M | -$2.42M | -$2.65M | -$2.79M | -$3.03M | -$1.08M |
| Depreciation & Amortization | $32 | $70 | $156 | $347 | $771 | $2K | $1K | $4.5M | $27K | $27K | $26K | $22K | $18K |
| Deferred Income Tax | $0 | $0 | $0 | $341K | -$179K | $132K | $0 | $0 | -$42K | -$18K | $0 | $0 | $0 |
| Stock-Based Compensation | $793K | $232K | $105K | $125K | $253K | $1.63M | $233K | $1.15M | $318K | $0 | $0 | $344K | $297K |
| Changes in Working Capital: | |||||||||||||
| Accounts Receivable | $114K | -$143K | $80K | $143K | $1.2M | -$1.39M | $81K | -$71K | $50K | $43K | $162K | -$19K | -$49K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $497K | -$277K | $0 | $0 | $0 | $0 |
| Other Working Capital | -$359K | -$19K | $309K | -$1.34M | $767K | $813K | $637K | $807K | $46K | $630K | $120K | -$56K | -$28K |
| Total Working Capital Change | -$245K | -$162K | $388K | -$1.19M | $1.97M | -$578K | $718K | $1.3M | -$231K | $673K | $282K | $116K | -$12K |
| Other Non-Cash Items | -$422K | $431K | $264K | $121K | -$80K | $74K | $73K | -$4.5M | $94K | $66K | -$110K | $357K | $65K |
| Net Cash from Operating | -$3.17M | -$1.33M | -$994K | -$4.27M | -$2.43M | -$4.18M | -$2.38M | -$1.88M | -$2.25M | -$1.88M | -$2.48M | -$2.19M | -$775K |
| Investing Activities | |||||||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | -$4K | $0 | $0 | -$1K | -$16K | -$23K | -$35K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$102K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$878K | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $120K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$102K | $0 | $0 | $0 | $120K | $0 | -$4K | $0 | -$878K | -$1K | -$16K | -$23K | -$35K |
| Financing Activities | |||||||||||||
| Debt Repaid | $350K | - | - | -$1.93M | -$1.63M | $1.29M | -$1.37M | - | -$875K | -$1.15M | - | - | - |
| Common Stock Issuance | $3.61M | $1.72M | $1.05M | $2.42M | $588K | $6.14M | $0 | $141K | $4.11M | $53K | $454K | $4.28M | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | -$46K | -$129K | -$50K | -$495K | $1.37M | $141K | $14K | $53K | $85K | $10K | $931K |
| Net Cash from Financing | $3.26M | $1.72M | $1.01M | $4.21M | $2.29M | $4.35M | $1.37M | $141K | $5M | $1.55M | $539K | $4.29M | $931K |
| Forex Effect | $23K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $6K | $385K | $14K | -$59K | -$27K | $164K | -$1.01M | -$1.74M | $2.75M | -$330K | -$1.96M | $2.07M | $120K |
| Supplementary Data | |||||||||||||
| Operating Cash Flow | -$3.17M | -$1.33M | -$994K | -$4.27M | -$2.43M | -$4.18M | -$2.38M | -$1.88M | -$2.25M | -$1.88M | -$2.48M | -$2.19M | -$775K |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -$4K | $0 | $0 | -$1K | -$16K | -$23K | -$35K |
| Free Cash Flow | -$3.17M | -$1.33M | -$994K | -$4.27M | -$2.43M | -$4.18M | -$2.39M | -$1.88M | -$2.25M | -$1.88M | -$2.5M | -$2.22M | -$810K |
| Cash at Beginning | $471K | $109K | $95K | $154K | $181K | $17K | $1.03M | $2.77M | $24K | $355K | $2.31M | $246K | $126K |
| Cash at End | $477K | $494K | $109K | $95K | $154K | $181K | $17K | $1.03M | $2.77M | $24K | $355K | $2.31M | $246K |